XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technologyGlobeNewsWire • 06/10/25
Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General MeetingBusiness Wire • 05/30/25
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?Zacks Investment Research • 05/28/25